Latest
Can Psilocybin Increase The Neurons In Your Brain?
This Is Your Brain On Drugs A research team from Yale has been exploring the effects of psychedelics on the brain. Their research has shown that a single dose of psilocybin is enough to cause …
Psychedelic Legalization Worries
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Delivery Methods, Music, Patents and More
</pre> Getting Under the Skin As more and more research hints at the potential therapeutic uses of psychedelics, finding new ways to deliver the powerful drugs has taken on new interest. Commonly administered forms of …
Ketamine One Subsidiary Signs Multiple Contracts
Ketamine One Subsidiary Secures Contracts Fresh off their acquisition of new OVR technology for virtual therapy enhancement; Vancouver based Ketamine One is rolling out more good news for investors. KGK Science Inc., a subsidiary of …
Clinical Trials Reaching New Levels
Revive Begins A New Phase Of Clinical Trials Toronto-based Revive Therapeutics is updating its development of psychedelics and clinical programs, moving towards a focus on psilocybin. Revive is advancing a psychedelic-based product pipeline that aims …
A Possible New Psychedelic Framework
Therapsil Applies Cannabis Legalization Strategy to Psilocybin Efforts B.C. non-profit organization Therapsil spent months drafting a 165-page proposal advocating for the therapeutic use of psilocybin as the legal and political battle continues in Canada. The …
Filament Is Going All Natural
Vancouver Company Seeks Approval For All Natural Psychedelics Vancouver-based Filament Health, a natural psychedelic drug development company, has expanded the scope of its research. The Backstory Filament is already licensed to work with psychoactive mushrooms. …
Making psychedelics at scale
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Ready Ketamine One
Ketamine One Expands to Veteran-Centric Markets in Canada The Preface In 2019, Health Canada approved the NeuroCatch Platform, a medical device developed by HealthTech Connex that measures cognitive brain functions. NeuroCatch is currently in use …
MDMA Therapy Access
MAPS-sponsored study on MDMA for PTSD by Numinus gets the go-ahead from Health Canada Vancouver’s Numinus Wellness announced that Health Canada issued a No Objection Letter to the company, giving them federal approval to proceed …